The Vasculitis Program, within the Rheumatology Unit at Massachusetts General Hospital provides individualized, cutting-edge care to patients with various forms of vasculitis. Our team of experts is dedicated to providing patients the most advanced care through personalized and comprehensive diagnosis and vasculitis treatment. We also lead innovative research in vasculitis and related conditions to improve outcomes for patients.
Vasculitis can affect blood vessels of different sizes, from small to medium to large. Our rheumatology providers in the Vasculitis Program have expertise in all forms of vasculitis, including but not limited to:
Our experts aim to establish prompt diagnosis and implement early treatment plans that can induce remission and prevent relapse of vasculitis in the long term. To maximize the effectiveness of vasculitis treatment and to minimize medication side effects, our approach relies on developing a personalized treatment plan for each patient.
Our comprehensive treatment approach brings close collaboration with specialists who have extensive experience in diagnosing and treating manifestations of vasculitis in different organs, including:
The care of patients with vasculitis requires expertise and careful attention to details of the disease course. Therefore, we will perform a careful review of symptoms and any prior testing, including review of radiographic studies and biopsies with our radiologists and pathologists, as necessary.
Our experts invest time in educating patients about their conditions and determining an individualized treatment plan that considers patients’ values and preferences.
The Rheumatology Vasculitis Program at MGH is hosting a continuing medical education (CME) course for healthcare providers involved in the care of patients with vasculitis and related conditions. Visit the official course website to learn more: 2025 Update in Vasculitis and Polymyalgia Rheumatica & Vasculitis Ultrasound Workshop
Our experts are advancing the field of vasculitis through innovative studies in ANCA-associated vasculitis, Giant Cell Arteritis, glucocorticoid toxicity, and other conditions. We perform a wide variety of research, including clinical trials, observational, and translational studies to discover new approaches to diagnosing and managing vasculitis.
We are actively enrolling patients in the following research studies:
Otolaryngology (MEE)
Stacey Turr Grey, MD
George A. Scangas, MD
Pulmonary and Critical Care
Fiona K. Gibbons, MD
Sydney B. Montesi, MD
Barry S. Shea, MD
Cardiology
Eric M. Isselbacher, MD
Vascular medicine
Ido Weinberg, MD
Cardiothoracic surgery
Jassar Arminder, MD
Michelle Isner, RN
Ophthalmology (MEE)
George N. Papaliodis, MD - Uveitis
Lucia Sobrin, MD, MPH – Retina and vitreous diseases
Neurology
Denis Balaban, MD
Nagagopal Venna, MD
Haatem M. Reda, MD
Neuro-ophthalmology
Joseph F. Rizzo, MD
Robert M. Mallery, MD
Bart Chwalisz, MD
Dermatology
Flavia Fedeles, MD
Evan Piette, MD
Janice Tiao, MD
Ruth Ann Vleugels, MD, MPH, MBA
Diagnostic Imaging (Radiology)
Sandeep S. Hedgire, MD
Brian B. Ghoshhajra, MD, MBA
Onofrio A. Catalano, MD, PhD
Amita Sharma, MBBS
Anushri Parakh, MBBS
Pathology
James R. Stone, MD, PhD
Maria Martinez-Lage Alvarez, MD (neuropathology)
Gastroenterology
Jay Luther, MD
Amandeep Singh, MD, PhD
Michael L. Dougan, MD, PhD
Infectious diseases
Camille N. Kotton, MD
Nephrology
Meghan E. Sise, MD
John L. Niles, MD
Reza Zonozi, MD
Anushya Jeyabalan, MD
